BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1602 related articles for article (PubMed ID: 8258695)

  • 1. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A; Ferrara P; Caput D
    Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM; Kumar A; Kryworuchko M; Diaz-Mitoma F
    J Immunol; 1996 Jul; 157(1):12-20. PubMed ID: 8683105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes.
    Donnelly RP; Freeman SL; Hayes MP
    J Immunol; 1995 Aug; 155(3):1420-7. PubMed ID: 7636207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
    Levesque MC; Haynes BF
    J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes.
    Geng Y; Zhang B; Lotz M
    J Immunol; 1993 Dec; 151(12):6692-700. PubMed ID: 8258685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
    Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
    J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide.
    Fouqueray B; Boutard V; Philippe C; Kornreich A; Marchant A; Perez J; Goldman M; Baud L
    Am J Pathol; 1995 Jul; 147(1):176-82. PubMed ID: 7604878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
    Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
    Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.
    Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A
    Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity.
    Smith DM; Lackides GA; Epstein LB
    Cancer Res; 1990 Jun; 50(11):3146-53. PubMed ID: 2334910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production.
    Bonder CS; Dickensheets HL; Finlay-Jones JJ; Donnelly RP; Hart PH
    J Immunol; 1998 Apr; 160(8):4048-56. PubMed ID: 9558115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
    J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.
    Chung IY; Benveniste EN
    J Immunol; 1990 Apr; 144(8):2999-3007. PubMed ID: 2109008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.
    Gessani S; Testa U; Varano B; Di Marzio P; Borghi P; Conti L; Barberi T; Tritarelli E; Martucci R; Seripa D
    J Immunol; 1993 Oct; 151(7):3758-66. PubMed ID: 7690813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 inhibits cytokine production by activated macrophages.
    Fiorentino DF; Zlotnik A; Mosmann TR; Howard M; O'Garra A
    J Immunol; 1991 Dec; 147(11):3815-22. PubMed ID: 1940369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH; Choi JH; Byun MS; Jue DM
    Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.